Abstract:The role of spinal cord -opioid receptor (MOR)-expressing dorsal horn neurons in nociception and morphine analgesia is incompletely understood. Using intrathecal dermorphin-saporin (Derm-sap) to selectively destroy MOR-expressing dorsal horn neurons, we sought to determine the role of these neurons in (1) normal baseline reflex nocifensive responses to noxious thermal stimulation (hotplate, tail flick) and to persistent noxious chemical stimulation (formalin) and (2) the antinociceptive activity of intrathecal… Show more
“…These areas also express opioid receptors, which localize to pre-synaptic terminals of primary sensory neurons as well as to their postsynaptic targets in laminae I and II (Kline and Wiley, 2008). In the present study, we found that MOR-IR neurons in the dorsal horn frequently expressed ER α .…”
We previously demonstrated that the spinal cord κ-opioid receptor (KOR) and μ-opioid receptor (MOR) form heterodimers (KOR/MOR). KOR/MOR formation and the associated KOR dependency of spinal morphine antinociception are most robust during proestrus. Using Sprague Dawley rats, we now demonstrate that (1) spinal synthesis of estrogen is critical to these processes, and (2) blockade of either estrogen receptor (ER) α-, β-, or G-protein-coupled ER1 or progesterone receptor (PR) substantially reduces KOR/MOR and eliminates mediation by KOR of spinal morphine antinociception. Effects of blocking ERs were manifest within 15 min, whereas those of PR blockade were manifest after 18 h, indicating the requirement for rapid signaling by estrogen and transcriptional effects of progesterone. Individual or combined blockade of ERs produced the same magnitude of effect, suggesting that they work in tandem as part of a macromolecular complex to regulate KOR/MOR formation. Consistent with this inference, we found that KOR and MOR were coexpressed with ERα and G-protein-coupled ER1 in the spinal dorsal horn. Reduction of KOR/MOR by ER or PR blockade or spinal aromatase inhibition shifts spinal morphine antinociception from KOR dependent to KOR independent. This indicates a sex steroid-dependent plasticity of spinal KOR functionality, which could explain the greater analgesic potency of KOR agonists in women versus men. We suggest that KOR/MOR is a molecular switch that shifts the function of KOR and thereby endogenous dynorphin from pronociceptive to antinociceptive. KOR/MOR could thus serve as a novel molecular target for pain management in women.
“…These areas also express opioid receptors, which localize to pre-synaptic terminals of primary sensory neurons as well as to their postsynaptic targets in laminae I and II (Kline and Wiley, 2008). In the present study, we found that MOR-IR neurons in the dorsal horn frequently expressed ER α .…”
We previously demonstrated that the spinal cord κ-opioid receptor (KOR) and μ-opioid receptor (MOR) form heterodimers (KOR/MOR). KOR/MOR formation and the associated KOR dependency of spinal morphine antinociception are most robust during proestrus. Using Sprague Dawley rats, we now demonstrate that (1) spinal synthesis of estrogen is critical to these processes, and (2) blockade of either estrogen receptor (ER) α-, β-, or G-protein-coupled ER1 or progesterone receptor (PR) substantially reduces KOR/MOR and eliminates mediation by KOR of spinal morphine antinociception. Effects of blocking ERs were manifest within 15 min, whereas those of PR blockade were manifest after 18 h, indicating the requirement for rapid signaling by estrogen and transcriptional effects of progesterone. Individual or combined blockade of ERs produced the same magnitude of effect, suggesting that they work in tandem as part of a macromolecular complex to regulate KOR/MOR formation. Consistent with this inference, we found that KOR and MOR were coexpressed with ERα and G-protein-coupled ER1 in the spinal dorsal horn. Reduction of KOR/MOR by ER or PR blockade or spinal aromatase inhibition shifts spinal morphine antinociception from KOR dependent to KOR independent. This indicates a sex steroid-dependent plasticity of spinal KOR functionality, which could explain the greater analgesic potency of KOR agonists in women versus men. We suggest that KOR/MOR is a molecular switch that shifts the function of KOR and thereby endogenous dynorphin from pronociceptive to antinociceptive. KOR/MOR could thus serve as a novel molecular target for pain management in women.
“…This suggests that in females, the PAG is not the primary anatomical substrate for the analgesic effects of morphine. Both the RVM (Porreca et al ., 2001; Burgess et al ., 2002) and the dorsal horn of the spinal cord (Kline & Wiley, 2008) contribute to morphine antihyperalgesia and perhaps these sites are more critical in females. In support, we have recently reported no differences in MOR expression within the lumbosacral spinal cord and similarly, no differences in ED 50 values for morphine when administered intrathecally (Ji et al ., 2006).…”
Section: Discussionmentioning
confidence: 99%
“…Thus, while vlPAG MOR obviously contributes to the effects of exogenous morphine, its reduction does not appear to alter endogenous pain modulation during inflammatory hyperalgesia suggesting that other pain inhibiting regions, including the RVM and spinal cord are involved. In support, previous studies have reported that DermSAP lesions of MOR-expressing neurons in the RVM (Porreca et al ., 2001; Burgess et al ., 2002) and dorsal horn neurons (Kline & Wiley, 2008) attenuate hyperalgesia in male rats. Together, these data indicate that the RVM and the dorsal horn of the spinal cord, but not the PAG, are essential for driving descending facilitation (Terayama et al ., 2000; Ren & Dubner, 2002; Dubner & Ren, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, dermorphin has been shown to have a high binding affinity selective for the MOR (K i value of 0.7mM) and that conjugation to saporin does not significantly alter its binding affinity (K i value of 0.1nM; Porreca et al ., 2001). This technique has been previously been shown to result in a significant attenuation of MOR expression in the RVM (Porreca et al ., 2001) and the spinal cord (Kline & Wiley, 2008). Loss of MOR containing neurons was confirmed in the present study using both immunohistochemistry and autoradiography.…”
Opioid-based narcotics are the most widely prescribed therapeutic agent for the alleviation of persistent pain; however, it is becoming increasingly clear that morphine is significantly less potent in women compared with men. Morphine primarily binds to -opioid receptors (MORs), and the periaqueductal gray (PAG) contains a dense population of MOR-expressing neurons. Via its descending projections to the rostral ventromedial medulla and the dorsal horn of the spinal cord, the PAG is considered an essential neural substrate for opioid-based analgesia. We hypothesized that MOR expression in the PAG was sexually dimorphic, and that these sex differences contribute to the observed sex differences in morphine potency. Using immunohistochemistry, we report that males had a significantly higher expression of MOR in the ventrolateral PAG compared with cycling females, whereas the lowest level of expression was observed in proestrus females. CFA-induced inflammatory pain produced thermal hyperalgesia in both males and females that was significantly reversed in males with a microinjection of morphine into the ventrolateral PAG; this effect was significantly greater than that observed in proestrus and estrus females. Selective lesions of MOR-expressing neurons in the ventrolateral PAG resulted in a significant reduction in the effects of systemic morphine in males only, and this reduction was positively correlated with the level of MOR expression in the ventrolateral PAG. Together, these results provide a mechanism for sex differences in morphine potency.
“…For example, substance P, which is coreleased from the central terminals, facilitates the relief of the Mg 21 block in the NMDA receptor, leading to the enhancement of NMDA receptor signaling (Khasabov et al, 2002;Suzuki et al, 2003). Other postsynaptic GPCRs that modulate NMDA receptors include metabotropic glutamate (D'Mello and Dickenson, 2008), CGRP (Yan and Yu, 2004), and m-opioid receptors (Gracy et al, 1997;Kline and Wiley, 2008). These receptors are known to couple to G q , G s , or G i proteins.…”
Section: Inhibition Of Inflammatory Pain By Mrgc Receptorsmentioning
Mas oncogene-related G protein-coupled receptor C (MrgC) is unequally expressed in sensory ganglia and has been shown to modulate pathologic pain. This study investigated the mechanism underlying the effect of MrgC receptors on inflammatory pain. Intrathecal administration of the selective MrgC receptor agonist bovine adrenal medulla 8-22 (BAM8-22) (30 nmol) inhibited complete Freund's adjuvant-evoked hyperalgesia. This was associated with the inhibition of protein kinase C-g and phosphorylated extracellular signal-regulated protein kinase in the spinal cord and/or dorsal root ganglia (DRG). The complete Freund's adjuvant injection in the hindpaw induced an increase in G q , but not G i and G s , protein in the spinal dorsal horn. This increase was inhibited by the intrathecal administration of BAM8-22. The exposure of DRG cultures to bradykinin (10 mM) and prostaglandin E2 (1 mM) increased the expression of calcitonin gene-related peptide (CGRP) and neuronal nitric oxide synthase in small-and medium-sized neurons as well as the levels of CGRP, aspartate, and glutamate in the cultured medium. The bradykinin/prostaglandin E 2 -induced alterations were absent in the presence of BAM8-22 (10 nM). These results suggest that the activation of MrgC receptors can modulate the increase in the expression of CGRP and neuronal nitric oxide synthase as well as the release of CGRP and excitatory amino acids in DRG associated with inflammatory pain. This modulation results in the inhibition of pain hypersensitivity by suppressing the expression of G q protein and protein kinase C-g and extracellular signal-regulated protein kinase signaling pathways in the spinal cord and/or DRG. The present study suggests that MrgC receptors may be a novel target for relieving inflammatory pain.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.